{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for methyl root_names_name in Any Name (approximate match)
Status:
US Previously Marketed
First approved in 1947
Class:
MIXTURE
Status:
US Previously Marketed
First approved in 1947
Class:
MIXTURE
Status:
Investigational
Source:
NCT03255070: Phase 1 Interventional Completed Breast Neoplasms
(2018)
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2024)
Source:
NDA218614
(2024)
Source URL:
First approved in 2024
Source:
NDA218614
Source URL:
Class:
NUCLEIC ACID
Status:
US Approved Rx
(2023)
Source:
NDA215842
(2023)
Source URL:
First approved in 2023
Source:
NDA215842
Source URL:
Class:
NUCLEIC ACID
Status:
US Approved Rx
(2023)
Source:
NDA217388
(2023)
Source URL:
First approved in 2023
Source:
NDA217388
Source URL:
Class:
NUCLEIC ACID
Status:
US Approved Rx
(2023)
Source:
NDA215887
(2023)
Source URL:
First approved in 2023
Source:
NDA215887
Source URL:
Class:
NUCLEIC ACID
Status:
US Approved Rx
(2021)
Source:
NDA214012
(2021)
Source URL:
First approved in 2021
Source:
NDA214012
Source URL:
Class:
NUCLEIC ACID
Status:
US Approved Rx
(2020)
Source:
NDA214103
(2020)
Source URL:
First approved in 2020
Source:
NDA214103
Source URL:
Class:
NUCLEIC ACID
